Controlled release sterile injectable aripiprazole formulation and method

Details for Australian Patent Application No. 2004285448 (hide)

Owner Otsuka Pharmaceutical Co., Ltd.

Inventors Naringrekar, Vijay H.; Nerurkar, Manoj; Kostanski, Janusz W.; Matsuda, Takakuni

Agent Davies Collison Cave

Pub. Number AU-B-2004285448

PCT Pub. Number WO2005/041937

Priority 60/513,618 23.10.03 US

Filing date 18 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 11 June 2009

International Classifications

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/041937 Priority application(s): WO2005/041937

11 June 2009 Application Accepted

  Published as AU-B-2004285448

8 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285449-Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors

2004285447-Pharmaceutical compositions